Some structural requirements for inhibition of type A and B forms of rabbit monoamine oxidase by tricyclic psychoactive drugs.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001921:Brain / Q000648:ultrastructure; D003641:Deamination; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008928:Mitochondria / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010627:Phenethylamines / Q000378:metabolism; D011817:Rabbits; D012701:Serotonin / Q000378:metabolism; D013329:Structure-Activity Relationship; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014439:Tyramine / Q000378:metabolism
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D014149:Tranquilizing Agents; D012701:Serotonin; D014439:Tyramine